Mizuho Boosts Cardinal Health (NYSE:CAH) Price Target to $120.00

Cardinal Health (NYSE:CAH) had its target price hoisted by research analysts at Mizuho from $110.00 to $120.00 in a report issued on Monday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Mizuho’s price objective indicates a potential upside of 1.99% from the stock’s current price.

Several other research firms have also weighed in on CAH. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday. Morgan Stanley upped their target price on Cardinal Health from $114.00 to $119.00 and gave the company an “overweight” rating in a research note on Thursday, August 15th. Citigroup dropped their price target on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. UBS Group boosted their price objective on shares of Cardinal Health from $125.00 to $134.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Finally, Evercore ISI lifted their target price on Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $121.50.

Cardinal Health Stock Up 1.3 %

Shares of Cardinal Health stock opened at $117.66 on Monday. The firm has a market cap of $28.47 billion, a price-to-earnings ratio of 34.01, a price-to-earnings-growth ratio of 1.49 and a beta of 0.60. Cardinal Health has a 52-week low of $93.17 and a 52-week high of $119.13. The company’s 50-day simple moving average is $111.75 and its 200-day simple moving average is $104.17.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.24. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The firm had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. During the same quarter in the prior year, the company posted $1.73 earnings per share. Cardinal Health’s quarterly revenue was down 4.3% on a year-over-year basis. Equities research analysts anticipate that Cardinal Health will post 7.61 EPS for the current year.

Insider Transactions at Cardinal Health

In other news, insider Jessica L. Mayer sold 17,896 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the transaction, the insider now directly owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CFO Aaron E. Alt sold 2,323 shares of Cardinal Health stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.93. Following the sale, the chief financial officer now directly owns 36,867 shares of the company’s stock, valued at $4,015,184.97. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the transaction, the insider now owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 113,963 shares of company stock valued at $12,379,980 over the last quarter. Company insiders own 0.09% of the company’s stock.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently made changes to their positions in CAH. Sigma Planning Corp grew its holdings in Cardinal Health by 20.2% during the third quarter. Sigma Planning Corp now owns 11,431 shares of the company’s stock valued at $1,263,000 after purchasing an additional 1,924 shares during the period. Atria Investments Inc grew its holdings in shares of Cardinal Health by 7.5% in the 3rd quarter. Atria Investments Inc now owns 12,810 shares of the company’s stock valued at $1,416,000 after buying an additional 899 shares during the period. Assetmark Inc. raised its stake in Cardinal Health by 25.8% during the 3rd quarter. Assetmark Inc. now owns 37,561 shares of the company’s stock worth $4,151,000 after buying an additional 7,692 shares during the period. CWA Asset Management Group LLC bought a new position in shares of Cardinal Health during the 3rd quarter valued at about $12,954,000. Finally, Fiera Capital Corp acquired a new stake in Cardinal Health during the 3rd quarter worth approximately $507,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.